Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma

Susu XU; Leiming WANG; Lihong ZHAO; Zhili HE; Liping GONG; Dehong LU; Lianghong TENG.
Chinese Journal of Pathology ; (12): 682-687, 2019.
Artículo en Zh | WPRIM | ID: wpr-797834

Documentos relacionados

  1. [Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma].
  2. [Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes].
  3. Targeted therapies in the medical management of craniopharyngioma.
  4. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy.
  5. Craniopharyngiomas: A clinicopathological and molecular study of 52 cases - Experience in the Complejo Hospitalario de Toledo and Hospital Universitario 12 de Octubre (Madrid).
  6. Study of ß-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
  7. [Etiology, Genetic Features and Clinical Presentations in Craniopharyngiomas].
  8. Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing.
  9. Craniopharyngioma in Pediatrics and Adults.
  10. Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.